curve lines
Thought Leadership

Whitepaper | Securing the Radiopharmaceutical Supply Chain

  • 25/06/2026
White paper Securing the Radiopharmaceutical Supply Chain

Securing the Radiopharmaceutical Supply Chain: From Structural Fragility to Strategic Alliance

Everyone in the industry has seen the $12–14 billion projection for 2030. This white paper addresses the main question: what would actually have to change across the full chain for that number to become real? 
 

Jean-Michel Geets, Principal Domain Expert & IBA Fellow
Louise Piron, Marketing Manager

Discover the 10 structural fault lines across supply and demand

  • Whitepaper IBA, the future of radiopharmaceuticals
    • 19/11/2025
    Whitepaper | The Future of Radiopharmaceuticals

    Radiopharma is rapidly evolving to meet rising patient demand. Radiopharmaceutical’s unique ability to diagnose and treat is unlocking new possibilities, but the future depends on how science, industry players and healthcare companies collaborate. 
     

    Cristiana Gameiro, PhD, Radiochemistry Domain Expert & IBA Fellow
    Jean-Michel Geets, Principal Domain Expert & IBA Fellow
    Louise Piron, Marketing Manager

    More details